Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 577.1389 ↑ 0.63%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option -1.64% 0.63% 0.79% -1.23% -0.91% -0.26% 23.33% 18.91% 19.99% 13.73%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.44% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.56%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology12.29%
Lupin LimitedPharmaceuticals & Biotechnology7.26%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology7.01%
Cipla LimitedPharmaceuticals & Biotechnology6.48%
Apollo Hospitals Enterprise LimitedHealthcare Services5.92%
Dr. Reddy's Laboratories LimitedPharmaceuticals & Biotechnology5.91%
Vijaya Diagnostic Centre LimitedHealthcare Services3.56%
MedPlus Health Services LimitedRetailing3.39%
Gland Pharma LimitedPharmaceuticals & Biotechnology3.24%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology2.99%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology2.85%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.71%
Abbott India LimitedPharmaceuticals & Biotechnology2.48%
Dr. Lal Path Labs LimitedHealthcare Services2.34%
Aurobindo Pharma LimitedPharmaceuticals & Biotechnology2.27%
Mankind Pharma LimitedPharmaceuticals & Biotechnology2.27%
Thyrocare Technologies LimitedHealthcare Services2.25%
Narayana Hrudayalaya LimitedHealthcare Services2.20%
Alkem Laboratories LimitedPharmaceuticals & Biotechnology2.16%
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology2.11%
Biocon LimitedPharmaceuticals & Biotechnology1.98%
Pfizer LimitedPharmaceuticals & Biotechnology1.98%
Suraksha Diagnostic LimitedHealthcare Services1.43%
IPCA Laboratories LimitedPharmaceuticals & Biotechnology1.35%
Torrent Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.35%
Sanofi India LimitedPharmaceuticals & Biotechnology1.32%
Fortis Healthcare LimitedHealthcare Services1.32%
Sanofi Consumer Healthcare India LimitedPharmaceuticals & Biotechnology1.24%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology0.99%
Syngene International LimitedHealthcare Services0.98%
Akums Drugs and Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.82%
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology0.74%
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology0.70%
Indoco Remedies LimitedPharmaceuticals & Biotechnology0.66%
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.43%
Zydus Lifesciences LimitedPharmaceuticals & Biotechnology0.23%
Concord Biotech LimitedPharmaceuticals & Biotechnology0.23%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV history

DateNAV
20 October, 2025577.1389
17 October, 2025573.5263
16 October, 2025572.3997
15 October, 2025569.4740
14 October, 2025569.3600
13 October, 2025572.6294
10 October, 2025572.0801
9 October, 2025566.2688
8 October, 2025562.1867
7 October, 2025564.9499
6 October, 2025563.4696
3 October, 2025561.0231
1 October, 2025559.2785
30 September, 2025553.4629
29 September, 2025555.3947
26 September, 2025555.7762
25 September, 2025566.9438
24 September, 2025571.5199
23 September, 2025575.1445
22 September, 2025577.4076
19 September, 2025584.3321
18 September, 2025581.8858
17 September, 2025578.3342
16 September, 2025577.9610
15 September, 2025576.6794
12 September, 2025578.7521
11 September, 2025576.6874
10 September, 2025574.6801
9 September, 2025572.5807
8 September, 2025571.0128

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 577.1389 as on 20 October, 2025.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -1.64% as on 20 October, 2025.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -0.26% as on 20 October, 2025.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 23.33% as on 20 October, 2025.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.91% as on 20 October, 2025.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.91% as on 20 October, 2025.